India, Sept. 5 -- CK Birla Hospital - CMRI, recently participated in India's first multicentric trial of Supernova stent retriever, a measure that is expected to reduce the cost of stroke therapy by more than 50 percent.
CK Birla Hospitals - CMRI was the only hospital in Eastern India that participated in the trial.
"This pioneering trial marks a significant milestone as the first-ever multicenter study in India focused on validating a new stent retriever device, showcasing India's growing capabilities in high-quality medical research and device validation," he said.
He said the trial initially focused on treating patients aged between 18 to 80 years.
"Now, once the trial has been successfully conducted, we can say that there is no ag...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.